Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Long-Term Debt Repayments (2021 - 2025)

Journey Medical's Long-Term Debt Repayments history spans 5 years, with the latest figure at $625000.0 for Q1 2025.

  • For the quarter ending Q1 2025, Long-Term Debt Repayments changed N/A year-over-year to $625000.0, compared with a TTM value of $625000.0 through Dec 2025, up 109.8%, and an annual FY2025 reading of $625000.0, down 50.0% over the prior year.
  • Long-Term Debt Repayments for Q1 2025 was $625000.0 at Journey Medical, roughly flat from $625000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $2.5 million in Q3 2021, with the low at -$9.0 million in Q3 2023.
  • Average Long-Term Debt Repayments over 5 years is $283333.3, with a median of $1.0 million recorded in 2021.
  • Year-over-year, Long-Term Debt Repayments rose 11.11% in 2022 and then plummeted 1000.0% in 2023.
  • Tracing DERM's Long-Term Debt Repayments over 5 years: stood at $2.5 million in 2021, then decreased by 20.0% to $2.0 million in 2022, then crashed by 550.0% to -$9.0 million in 2023, then skyrocketed by 106.94% to $625000.0 in 2024, then changed by 0.0% to $625000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Long-Term Debt Repayments are $625000.0 (Q1 2025), $625000.0 (Q4 2024), and -$9.0 million (Q3 2023).